Direct conversion of human fibroblasts into dopaminergic neural progenitor-like cells using TAT-mediated protein transduction of recombinant factors

Biochemical and Biophysical Research Communications
Fahimeh MirakhoriHossein Baharvand

Abstract

Recent progress in the generation of induced neural progenitor cells (iNPCs) holds tremendous potential for regenerative medicine. However, a major limitation is the lack of a reliable source for cell replacement therapy in neurological diseases such as Parkinson's disease (PD). Here, we show that the combination of small molecules (SM) and TAT-mediated protein transduction of SOX2 and LMX1a in a 3D sphere culture directly convert human fibroblasts to induced dopaminergic neural progenitor-like cells (iDPCs). The generated iDPCs expressed various NPC markers (SOX2, PAX6, NESTIN, OLIG2) and midbrain progenitor markers (EN1, LMX1a, FOXA2, WNT1) as detected by immunostaining and real-time PCR. Following differentiation, the majority of cells expressed neuronal dopaminergic markers as indicated by co-expression of TH with NURR1, and/or PITX3. We found that SOX2 and LMX1a TAT-mediated protein transduction in the combination of SM could directly convert human fibroblasts to self-renewal iDPCs. In conclusion, to our best knowledge, this is the first report of generation of safe DPCs and may suggest an alternative strategy for cell therapy for the treatment of neurodegenerative disorders.

References

Jan 7, 2010·The Journal of Clinical Investigation·Olle Lindvall, Zaal Kokaia
Apr 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Wenlin LiSheng Ding
Jun 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ulrich PfistererMalin Parmar
Nov 23, 2011·Cell Research·Xinjian LiuChuan-Yuan Li
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ernesto LujanMarius Wernig
Mar 27, 2012·Cell Stem Cell·Dong Wook HanHans R Schöler
Mar 27, 2012·Cell Stem Cell·Marc ThierFrank Edenhofer
Apr 10, 2012·Nature Methods·Julia LadewigOliver Brüstle
Nov 19, 2013·Journal of Cellular Physiology·Fahimeh MirakhoriHossein Baharvand
Dec 3, 2014·Stem Cell Reports·John P CassadyRudolf Jaenisch

❮ Previous
Next ❯

Citations

Apr 2, 2016·The Veterinary Journal·T A L BreviniF Gandolfi
Jan 23, 2017·Redox Biology·Zhimin XuJian Feng
Oct 21, 2016·Human Gene Therapy·Qingxi ZhangTongxiang Lin
Oct 5, 2018·Current Neurology and Neuroscience Reports·S L SisonA D Ebert
Mar 22, 2020·Journal of Assisted Reproduction and Genetics·G PennarossaT A L Brevini
Feb 20, 2020·Biochemical and Biophysical Research Communications·Alireza PouyaHossein Baharvand
Sep 25, 2017·Methods : a Companion to Methods in Enzymology·Ebrahim ShahbaziHossein Baharvand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.